Treasury
3-MO 4.26% -1bp 6-MO 4.36% -1bp 1-YR 4.51% +1bp 2-YR 4.79% +2bp 3-YR 4.86% +1bp 5-YR 4.94% unch 7-YR 5.02% -2bp 10-YR 5.12% -3bp 20-YR 5.47% -6bp 30-YR 5.42% -6bp 3-MO 4.26% -1bp 6-MO 4.36% -1bp 1-YR 4.51% +1bp 2-YR 4.79% +2bp 3-YR 4.86% +1bp 5-YR 4.94% unch 7-YR 5.02% -2bp 10-YR 5.12% -3bp 20-YR 5.47% -6bp 30-YR 5.42% -6bp 3-MO 4.26% -1bp 6-MO 4.36% -1bp 1-YR 4.51% +1bp 2-YR 4.79% +2bp 3-YR 4.86% +1bp 5-YR 4.94% unch 7-YR 5.02% -2bp 10-YR 5.12% -3bp 20-YR 5.47% -6bp 30-YR 5.42% -6bp 3-MO 4.26% -1bp 6-MO 4.36% -1bp 1-YR 4.51% +1bp 2-YR 4.79% +2bp 3-YR 4.86% +1bp 5-YR 4.94% unch 7-YR 5.02% -2bp 10-YR 5.12% -3bp 20-YR 5.47% -6bp 30-YR 5.42% -6bp 3-MO 4.26% -1bp 6-MO 4.36% -1bp 1-YR 4.51% +1bp 2-YR 4.79% +2bp 3-YR 4.86% +1bp 5-YR 4.94% unch 7-YR 5.02% -2bp 10-YR 5.12% -3bp 20-YR 5.47% -6bp 30-YR 5.42% -6bp 3-MO 4.26% -1bp 6-MO 4.36% -1bp 1-YR 4.51% +1bp 2-YR 4.79% +2bp 3-YR 4.86% +1bp 5-YR 4.94% unch 7-YR 5.02% -2bp 10-YR 5.12% -3bp 20-YR 5.47% -6bp 30-YR 5.42% -6bp
US Treasury par yield curve · Oct 20 · Source: U.S. Treasury
Wednesday, October 21, 2026
U.S. Edition
MONEY & WORLD
Subscribe
Third quarter

Thermo Fisher grows third-quarter revenue 9 percent to $12.14bn as adjusted EPS climbs to $6.68

Money & World
The Editorial Team ·
Red Thermo Fisher Scientific lettering above the glass entrance of a brick company building in Waltham, Massachusetts, photographed in 2009.
Photo: Coolcaesar / Wikimedia Commons (CC BY-SA 3.0)

Thermo Fisher Scientific grew third-quarter revenue 9 percent to $12.14bn, with organic growth of 6 percent, according to its results release filed with the SEC before Wednesday's open.

Adjusted earnings per share rose 15 percent to $6.68 from $5.79. On a GAAP basis, diluted earnings were $4.64 a share, against $4.27 a year earlier, and operating margin widened to 18.6 percent from 17.4 percent.

The laboratory products and biopharma services segment carried the quarter, with revenue of $6.86bn against $5.97bn a year before, while specialty diagnostics fell to $1.10bn from $1.17bn in the quarter the company completed the sale of its microbiology business. Free cash flow was $2.12bn.

The release gives no new full-year numbers. Thermo Fisher said it would update its 2026 guidance on its 7:00 a.m. Eastern call.

The document: Thermo Fisher Scientific, Form 8-K exhibit 99.1, third-quarter 2026 results, October 21, 2026.

More on Finance